bioRxiv Science⌕ Search

Biology subjects

Lomonaco, T.

Publications and source records attributed to Lomonaco, T..

2 recordsLinked to original sources

The volatile fatty-acid fingerprint of human fear

Human axillary odour can convey information about emotional state, but the molecular composition of fear related volatile emissions remains undefined. Here, we combine low background dual chamber axillary sampling, synchronous real time and offline mass spectrometry, chemical domain group independent component analysis and hierarchical Bayesian modelling to identify a molecular finger-print of acute fear during immersive virtual reality fear induction. In 37 healthy adults, this framework recovered five axillary volatile components associated with a continuous physiology derived fear index. The fingerprint comprised increased emissions of acetic, butyric, caproic and caprylic acids, octanal and acetone, together with decreased sulcatone, decanal, geranylacetone and citraconic anhydride. This coordinated pattern was reproducible across individuals and emerged from unsupervised chemical decomposition followed by regularised Bayesian selection, without prior biochemical constraints. Posterior predictive checks and leave one participant out refitting supported its robustness within the cohort. Its composition and directionality are consistent with sympathetic autonomic metabolic mobilisation, suggesting contributions from fatty acid handling, acetone related metabolism and axillary gland output. These findings define a candidate molecular cue of acute human fear and establish a replicable methodological template for decoding the chemical language of human emotion.

neuroscience↗

AI-driven Classification of Heart Failure Preserved and Reduced Ejection Fraction Patients Using the Total Protein Approach

Heart failure (HF) presents two major subtypes: HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF), each one with distinct metabolic characteristics. This study utilized artificial intelligence, high-resolution mass spectrometry and the Total Protein Approach (TPA) to identify key features differentiating these subtypes. Aldolase A (ALDOA), a glycolytic enzyme, was found upregulated in HFrEF patients, reflecting an increased glycolysis pathway, while Arginase 1 (ARG1), a key enzyme in the urea cycle, was also elevated, indicating an increased urea pathway. In contrast, HFpEF patients showed TPA ALDOA and ARG1 levels similar to healthy controls. The combined use of ALDOA and ARG1 TPA values successfully classified 82% of patients (14 out of 17). Additionally, most HFpEF patients were over 80 years old, suggesting an age-related metabolic shift. The combination of ALDOA and ARG1 are promising biomarkers for distinguishing HFpEF and HFrEF using the TPA approach, with potential implications for targeted therapies.

biochemistry↗